Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Esperion Therapeutics, Inc. (ESPR)

« Back to company index

ESPR Chatter Timeline

Stock Ticker for ESPR

Most Active Tweeters for ESPR

UserTweets
@Tickeron 12
@WeekHerald 3
@ZolmaxNews 3
@stocknewstimes 3
@registrarjourn 2

Recent Tweets for ESPR

Tickeron @Tickeron
$ESPR's 10-day Moving Average broke above its 50-day Moving Average on October 14, 2019. View odds for this and oth… https://t.co/K92zpWJoNT
October 21st 2019, 7:10pm
Tickeron @Tickeron
$ESPR's 10-day Moving Average crossed above its 50-day Moving Average on October 14, 2019. View odds for this and o… https://t.co/PuFPLdBJcz
October 20th 2019, 6:10pm
Tickeron @Tickeron
$ESPR's 10-day Moving Average crossed above its 50-day Moving Average on October 14, 2019. View odds for this and o… https://t.co/6su6q97y23
October 19th 2019, 9:10pm
dailypoliticaln @dailypoliticaln
Brokerages Set Esperion Therapeutics Inc $ESPR Target Price at $72.33 https://t.co/2sHcNLpOur
October 19th 2019, 12:10pm
ZolmaxNews @ZolmaxNews
Analysts Set Esperion Therapeutics Inc $ESPR Target Price at $72.33 https://t.co/BcDLvNtu5x
October 19th 2019, 12:10pm
OlympiaReport @OlympiaReport
Esperion Therapeutics $ESPR Lifted to “Sell” at BidaskClub https://t.co/mup0KG5J62
October 19th 2019, 8:10am
WeekHerald @WeekHerald
Esperion Therapeutics $ESPR Lifted to “Sell” at BidaskClub https://t.co/BAPoDUFzjX
October 19th 2019, 8:10am
Tickeron @Tickeron
$ESPR's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram crosses above signal line. View odds for… https://t.co/w7P6rEXD3g
October 19th 2019, 1:10am
NoraRubya3 @NoraRubya3
RT @man_sca: $ESPR why down? Hopes for a buyout have been reduced! Nevertheless, Espr has its value and its advantages which will soon be v…
October 19th 2019, 12:10am
registrarjourn @registrarjourn
Esperion Therapeutics $ESPR Lifted to Sell at BidaskClub https://t.co/qn5Nso0n7i
October 18th 2019, 2:10pm
EnterpriseLeade @EnterpriseLeade
Esperion Therapeutics $ESPR Lifted to Sell at BidaskClub https://t.co/gOAshm7tPN
October 18th 2019, 2:10pm
dispatchtribune @dispatchtribune
Esperion Therapeutics $ESPR Upgraded to Sell by BidaskClub https://t.co/3RsFfXigZx
October 18th 2019, 2:10pm
ZolmaxNews @ZolmaxNews
Esperion Therapeutics Inc $ESPR Short Interest Update https://t.co/loivjTGAeA
October 18th 2019, 4:10am
Tickeron @Tickeron
$ESPR's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram crosses above signal line. View odds for… https://t.co/PcKKGIkAEQ
October 17th 2019, 8:10pm
TrendSpider @TrendSpider
$ESPR Update. https://t.co/7IpFNz3WNp
October 17th 2019, 4:10pm
stocknewstimes @stocknewstimes
Esperion Therapeutics Inc $ESPR Sees Large Decrease in Short Interest https://t.co/KfWaOCZNmO
October 17th 2019, 1:10pm
TranscriptDaily @TranscriptDaily
Esperion Therapeutics Inc $ESPR Sees Large Decrease in Short Interest https://t.co/2ClVGngodt
October 17th 2019, 1:10pm
WeekHerald @WeekHerald
Esperion Therapeutics Inc $ESPR Receives $72.33 Consensus Price Target from Brokerages https://t.co/cprlhx4GWg
October 17th 2019, 12:10pm
stocknewstimes @stocknewstimes
Esperion Therapeutics $ESPR Stock Rating Upgraded by BidaskClub https://t.co/f60XS8xe9g
October 17th 2019, 5:10am
TranscriptDaily @TranscriptDaily
Esperion Therapeutics $ESPR Stock Rating Upgraded by BidaskClub https://t.co/1RHVTrovLJ
October 17th 2019, 5:10am
Tickeron @Tickeron
$ESPR in Uptrend: price expected to rise as it breaks its lower Bollinger Band on September 3, 2019. View odds for… https://t.co/EgZgIld0Kg
October 16th 2019, 8:10pm
TickerReport @TickerReport
Esperion Therapeutics Inc $ESPR Short Interest Down 7.0% in September https://t.co/Xs5XhEKYfM
October 16th 2019, 4:10pm
AmericanBanking @AmericanBanking
Esperion Therapeutics Inc $ESPR Short Interest Down 7.0% in September https://t.co/0ZknYmNf4g #stocks
October 16th 2019, 4:10pm
IRAMarketReport @IRAMarketReport
Esperion Therapeutics $ESPR Upgraded to “Sell” by BidaskClub https://t.co/nf7yuSL69b #markets
October 16th 2019, 8:10am
chaffeybreeze @chaffeybreeze
Esperion Therapeutics $ESPR Upgraded to “Sell” by BidaskClub https://t.co/YjwzJV1OvE #stocks
October 16th 2019, 8:10am
WatchlistN @WatchlistN
Esperion Therapeutics $ESPR Upgraded to “Sell” by BidaskClub https://t.co/obBFEfgmZs
October 16th 2019, 8:10am
Tickeron @Tickeron
$ESPR enters an Uptrend as Momentum Indicator exceeded the 0 level on October 11, 2019. View odds for this and othe… https://t.co/JQBio7vrVI
October 15th 2019, 7:10pm
Tickeron @Tickeron
$ESPR enters an Uptrend as Momentum Indicator exceeded the 0 level on October 11, 2019. View odds for this and othe… https://t.co/O6BL5Ukt7F
October 14th 2019, 7:10pm
AmericanBanking @AmericanBanking
Esperion Therapeutics Inc $ESPR Receives Average Recommendation of “Buy” from Brokerages https://t.co/wBG2IysEnQ #stocks
October 14th 2019, 11:10am
QuantchaIdeas @QuantchaIdeas
StockTwits Trending Alert: Trading recent interest in ESPERION THERAPEUTICS INC. CO $ESPR https://t.co/8BiB8pVUhr https://t.co/A29m7HKBby
October 14th 2019, 11:10am
QuantchaIdeas @QuantchaIdeas
Covered Call Alert: ESPERION THERAPEUTICS INC. CO $ESPR returning up to 42.21% through 20-Mar-2020… https://t.co/IQtxcCMRMm
October 14th 2019, 10:10am
gcassidy718 @gcassidy718
$ESPR I’ll probably buy on the dip. Still need to do more research. 3.81 % https://t.co/ZJ7rwkXcgV
October 13th 2019, 4:10pm
BlueBioNow @BlueBioNow
$ESPR blockbuster 3.81 % change recently https://t.co/ZFif3yYmEW
October 13th 2019, 2:10am
Tickeron @Tickeron
$ESPR enters an Uptrend because Momentum Indicator exceeded the 0 level on October 11, 2019. View odds for this and… https://t.co/Buf9p3MmAy
October 13th 2019, 12:10am
macondailynews @macondailynews
Esperion Therapeutics Inc $ESPR Expected to Announce Quarterly Sales of $930,000.00 https://t.co/B1TxQyWJtQ
October 12th 2019, 10:10pm
TheMarketsDaily @TheMarketsDaily
Zacks: Analysts Anticipate Esperion Therapeutics Inc $ESPR Will Announce Quarterly Sales of $930,000.00 https://t.co/RUrHahrfJJ
October 12th 2019, 10:10pm
stocknewstimes @stocknewstimes
Esperion Therapeutics Inc $ESPR Expected to Announce Quarterly Sales of $930,000.00 https://t.co/RJL2fyjhot
October 12th 2019, 10:10pm
BlueBioNow @BlueBioNow
$ESPR is on the move with significant price changes 3.19 % https://t.co/ZFif3yGLgm
October 12th 2019, 1:10am
Tickeron @Tickeron
$ESPR's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram just turned positive. View odds for this… https://t.co/UH4eEiNabW
October 10th 2019, 9:10pm
man_sca @man_sca
@BrianSkorney $espr and $amrn kill pcsk9
October 10th 2019, 4:10pm
gcassidy718 @gcassidy718
$ESPR I’ll probably buy on the dip. Still need to do more research. 2.13 % https://t.co/ZJ7rwkXcgV
October 10th 2019, 4:10pm
ZolmaxNews @ZolmaxNews
Analysts Anticipate Esperion Therapeutics Inc $ESPR Will Post Earnings of -$2.01 Per Share https://t.co/aRG9qLOaO8
October 10th 2019, 1:10am
Tickeron @Tickeron
$ESPR's price moved below its 50-day Moving Average on October 7, 2019. View odds for this and other indicators:… https://t.co/lEv3njKZPv
October 9th 2019, 8:10pm
dakotafinancial @dakotafinancial
$930,000.00 in Sales Expected for Esperion Therapeutics Inc $ESPR This Quarter https://t.co/ayJbQyJu5W
October 9th 2019, 6:10pm
dispatchtribune @dispatchtribune
Brokerages Expect Esperion Therapeutics Inc $ESPR to Announce -$2.01 EPS https://t.co/iCQTYRQfB0
October 9th 2019, 12:10am
EnterpriseLeade @EnterpriseLeade
Zacks: Analysts Expect Esperion Therapeutics Inc $ESPR to Announce -$2.01 EPS https://t.co/abZxbNwlmk
October 9th 2019, 12:10am
registrarjourn @registrarjourn
Zacks: Analysts Expect Esperion Therapeutics Inc $ESPR to Announce -$2.01 EPS https://t.co/mUun6bZ7m3
October 9th 2019, 12:10am
Tickeron @Tickeron
$ESPR's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram crosses above signal line. View odds for… https://t.co/wDzrBHiZ5B
October 8th 2019, 7:10pm
UnusualActivit3 @UnusualActivit3
Esperion Therapeutics Inc. $ESPR down by -2.76% at $36.26 UNUSUAL ACTIVITY VOLUME 1234.61% STRENGTH 1393.33% #Stocks #UnusualActivity
October 8th 2019, 10:10am
dakotafinancial @dakotafinancial
Esperion Therapeutics $ESPR Stock Rating Upgraded by ValuEngine https://t.co/V1IGJ9bimw
October 8th 2019, 2:10am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.